Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 28, 2011 01:15 ET | Source: Novartis Pharma AG

Novartis to commence subsequent offering period for Genoptix, Inc.

Basel, February 28, 2011 - Novartis announced today that the initial offering period of its previously announced cash tender offer to purchase all outstanding shares of common stock of Genoptix,...
February 28, 2011 01:00 ET | Source: Novartis Pharma AG

Novartis schedules Extraordinary Shareholder Meeting to vote on Alcon merger for April 8

Basel, February 28, 2011 - Novartis announced that it has scheduled an Extraordinary General Meeting (EGM) on April 8, 2011, where Novartis shareholders will vote on the proposed merger with Alcon,...
February 22, 2011 11:59 ET | Source: Novartis Pharma AG

Les actionnaires approuvent l'ensemble des résolutions proposées par le Conseil d'administration de Novartis

Les actionnaires approuvent la 14e hausse consécutive du dividende par action à CHF 2,20 (+5 %) au titre de l'exercice 2010. Le dividende distribué, en augmentation constante depuis la création de...
February 22, 2011 11:59 ET | Source: Novartis Pharma AG

Aktionäre folgen sämtlichen Empfehlungen des Verwaltungsrats von Novartis

Aktionäre genehmigen Dividendenerhöhung auf CHF 2.20 pro Aktie (+5%) für 2010 - dies entspricht einer Ausschüttungsquote von rund 55% des Reingewinns aus fortzuführenden Geschäftsbereichen und ist die...
February 22, 2011 11:59 ET | Source: Novartis Pharma AG

Shareholders approve all proposed resolutions of Novartis Board of Directors

Shareholders approve 14th consecutive dividend increase to CHF 2.20 (+5%) per share for 2010, representing a payout of approximately 55% of net income from continuing operations, marking continued...
February 18, 2011 08:04 ET | Source: Novartis Pharma AG

Novartis gains positive CHMP opinion for Rasilamlo(TM), a single-pill combination of aliskiren and amlodipine to treat high blood pressure

Rasilamlo combines in a single pill the only approved direct renin inhibitor, Rasilez, with the widely used calcium channel blocker amlodipine Data from over 5,000 mild-to-severe high blood...
February 17, 2011 01:00 ET | Source: Novartis Pharma AG

Novartis nomme Naomi Kelman directrice de la division Novartis OTC

Novartis OTC (Over-the-Counter) devient une division distincte au sein du portefeuille diversifié des soins de santé du Groupe, avec Naomi Kelman à sa tête, sous la responsabilité de Joseph Jimenez,...
February 17, 2011 01:00 ET | Source: Novartis Pharma AG

Novartis ernennt Naomi Kelman zur neuen Leiterin der OTC-Division von Novartis

Novartis OTC (Over-the-Counter, Selbstmedikation) wird im Rahmen des diversifizierten Konzernportfolios in Zukunft als separate Division geführt - wobei Kelman an Joseph Jimenez, den CEO von...
February 17, 2011 01:00 ET | Source: Novartis Pharma AG

Novartis appoints Naomi Kelman as new Head of the Novartis OTC division

Novartis OTC (Over-the-Counter) to become separate division in the group's diversified healthcare portfolio with Kelman reporting to Joseph Jimenez, CEO of Novartis Basel, February 17, 2011 -...
February 10, 2011 03:42 ET | Source: Novartis Pharma AG

Novartis studies show Onbrez® Breezhaler® plus tiotropium provided greater increase in lung function than tiotropium alone

Two Phase III studies demonstrated efficacy benefits of combining once-daily Onbrez Breezhaler 150 mcg with tiotropium in patients with COPD[1],[2] INTRUST 1 and 2 studies add to comprehensive...